Skip to main content
. 2017 May 26;31(12):2630–2641. doi: 10.1038/leu.2017.122

Figure 3.

Figure 3

Kaplan–Meier curves for PFS by time to relapse in the ASPIRE trial (1R1T group): (a) early relapsers and (b) late relapsers. Vertical dashed line indicates the time point after which carfilzomib was discontinued according to study protocol. Early relapsers refers to patients relapsing <12 months post-ASCT. Late relapsers refers to patients relapsing ⩾12 months post-ASCT.